{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:16:10Z","timestamp":1791404170860,"version":"4.3.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,3,30]],"date-time":"2010-03-30T00:00:00Z","timestamp":1269907200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1471-2334-10-83","type":"journal-article","created":{"date-parts":[[2010,3,30]],"date-time":"2010-03-30T18:14:38Z","timestamp":1269972878000},"source":"Crossref","is-referenced-by-count":22,"title":["Clinical deterioration during antituberculosis treatment in Africa: Incidence, causes and risk factors"],"prefix":"10.1186","volume":"10","author":[{"given":"Dominique J","family":"Pepper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzaan","family":"Marais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feriyl","family":"Bhaijee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Maartens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"McIlleron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"De Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"McDermid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simiso","family":"Sokhela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janisha","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Meintjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,30]]},"reference":[{"issue":"5","key":"1063_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1056\/NEJM199101313240503","volume":"324","author":"PM Small","year":"1991","unstructured":"Small PM, Schecter GF, Goodman PC, Sande MA, Chaisson RE, Hopewell PC: Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med. 1991, 324 (5): 289-94.","journal-title":"N Engl J Med"},{"issue":"5","key":"1063_CR2","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/00042560-200204150-00001","volume":"29","author":"M Plana","year":"2002","unstructured":"Plana M, Mart\u00ednez C, Garc\u00eda F, Maleno MJ, Barcel\u00f3 JJ, Garc\u00eda A, Lejeune M, Vidal C, Cruceta A, Mir\u00f3 JM, Pumarola T, Gallart T, Gatell JM: Immunologic reconstitution after 1 year of highly active antiretroviral therapy, with or without protease inhibitors. J Acquir Immune Defic Syndr. 2002, 29 (5): 429-34.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9534","key":"1063_CR3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0140-6736(06)69152-6","volume":"368","author":"MT May","year":"2006","unstructured":"May MT, Sterne JA, Costagliola D, Sabin CA, Phillips AN, Justice AC, Dabis F, Gill J, Lundgren J, Hogg RS, de Wolf F, F\u00e4tkenheuer G, Staszewski S, d'Arminio Monforte A, Egger M, Antiretroviral Therapy (ART) Cohort Collaboration: HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis. Lancet. 2006, 368 (9534): 451-8. 10.1016\/S0140-6736(06)69152-6.","journal-title":"Lancet"},{"issue":"2","key":"1063_CR4","doi-asserted-by":"publisher","first-page":"e4520","DOI":"10.1371\/journal.pone.0004520","volume":"4","author":"DJ Pepper","year":"2009","unstructured":"Pepper DJ, Rebe K, Morroni C, Wilkinson RJ, Meintjes G: Clinical deterioration during antituberculosis treatment at a district hospital in South Africa: the importance of drug resistance and AIDS defining illnesses. PLoS One. 2009, 4 (2): e4520-10.1371\/journal.pone.0004520.","journal-title":"PLoS One"},{"issue":"8","key":"1063_CR5","first-page":"848","volume":"11","author":"R Zachariah","year":"2007","unstructured":"Zachariah R, Fitzgerald M, Massaquoi M, Acabu A, Chilomo D, Salaniponi FM, Harries AD: Does antiretroviral treatment reduce case fatality among HIV-positive patients with tuberculosis in Malawi?. Int J Tuberc Lung Dis. 2007, 11 (8): 848-53.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1063_CR6","volume-title":"CROI","author":"SA Karim","year":"2009","unstructured":"Karim SA, Naidoo K, Grobler A, Padayatchi N, Nair G, Bamber S, Pienaar J, Friedland G, El-Sadr W, Karim QA: Initiating ART during TB Treatment Significantly Increases Survival: Results of a Randomized Controlled Clinical Trial in TB\/HIV-co-infected Patients in South Africa. CROI. 2009, [\n                    http:\/\/www.retroconference.org\/2009\/Abstracts\/34255.htm\n                    \n                  ] Abstract #36a Session 8 Oral Abstracts Prevention and Treatment of Serious OIs and Malignancies"},{"issue":"8","key":"1063_CR7","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1473-3099(08)70184-1","volume":"8","author":"G Meintjes","year":"2008","unstructured":"Meintjes G, Lawn SD, Scano F, Maartens G, French MA, Worodria W, Elliott JH, Murdoch D, Wilkinson RJ, Seyler C, John L, Loeff van der MS, Reiss P, Lynen L, Janoff EN, Gilks C, Colebunders R, International Network for the Study of HIV-associated IRIS: Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008, 8 (8): 516-23. 10.1016\/S1473-3099(08)70184-1.","journal-title":"Lancet Infect Dis"},{"key":"1063_CR8","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.drudis.2007.08.001","volume":"12","author":"DJ Pepper","year":"2007","unstructured":"Pepper DJ, Meintjes GA, McIlleron H, Wilkinson RJ: Combined therapy for tuberculosis and HIV-1: the challenge for drug discovery. Drug Discov Today. 2007, 12: 980-9. 10.1016\/j.drudis.2007.08.001.","journal-title":"Drug Discov Today"},{"key":"1063_CR9","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1128\/AAC.50.4.1170-1177.2006","volume":"50","author":"H McIlleron","year":"2006","unstructured":"McIlleron H, Wash P, Burger A, Norman J, Folb PI, Smith P: Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol pharmacokinetics in a cohort of tuberculosis patients. Antimicrob Agents Chemother. 2006, 50: 1170-7. 10.1128\/AAC.50.4.1170-1177.2006.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9693","key":"1063_CR10","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0140-6736(09)60916-8","volume":"374","author":"SS Karim","year":"2009","unstructured":"Karim SS, Churchyard GJ, Karim QA, Lawn SD: HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet. 2009, 374 (9693): 921-33. 10.1016\/S0140-6736(09)60916-8.","journal-title":"Lancet"},{"issue":"11","key":"1063_CR11","first-page":"919","volume":"2","author":"C Connolly","year":"1998","unstructured":"Connolly C, Davies GR, Wilkinson D: Impact of the human immunodeficiency virus epidemic on mortality among adults with tuberculosis in rural South Africa, 1991-1995. Int J Tuberc Lung Dis. 1998, 2 (11): 919-25.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9","key":"1063_CR12","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.trstmh.2007.04.023","volume":"101","author":"J Zwang","year":"2007","unstructured":"Zwang J, Garenne M, Kahn K, Collinson M, Tollman SM: Trends in mortality from pulmonary tuberculosis and HIV\/AIDS co-infection in rural South Africa (Agincourt). Trans R Soc Trop Med Hyg. 2007, 101 (9): 893-8. 10.1016\/j.trstmh.2007.04.023.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1063_CR13","unstructured":"Results of the 2006 HIV-1 Antenatal Provincial and Area Surveys. 2007, Cape Town: Western Cape Provincial Department of Health"},{"key":"1063_CR14","unstructured":"South African National Tuberculosis Control Programme Practical guidelines. [Accessed 7 September 2009]., [\n                    http:\/\/www.doh.gov.za\/aids\/docs\/tuberculosis.html\n                    \n                  ]"},{"key":"1063_CR15","unstructured":"South African Department of Health HIV-1 and AIDS and STI strategic plan for South Africa 2007-2011. [Accessed 7 September 2009]., [\n                    http:\/\/www.info.gov.za\/otherdocs\/2007\/aidsplan2007\/index.html\n                    \n                  ]"},{"key":"1063_CR16","unstructured":"World Health Organization: Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents recommendations for HIV-1-prevalent and resource-constrained settings. [Accessed 7 September 2009]., [\n                    http:\/\/www.who.int\/tb\/publications\/2006\/tbhiv_recommendations.pdf\n                    \n                  ]"},{"key":"1063_CR17","unstructured":"Hain Lifescience: GenoType MTBDRplus, version 1.0. [Accessed 24 September 2009]., [\n                    http:\/\/www.hain-lifescience.de\/en\/products\/microbiology\/mycobacteria\/genotype-mtbdrplus.html\n                    \n                  ]"},{"key":"1063_CR18","unstructured":"WHO: HIV Clinical Staging. [Accessed 24 September 2009]., [\n                    http:\/\/www.who.int\/hiv\/pub\/guidelines\/clinicalstaging.pdf\n                    \n                  ]"},{"key":"1063_CR19","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1056\/NEJMoa062360","volume":"355","author":"El Sadr","year":"2006","unstructured":"El Sadr , et al: CD4+ Count-Guided Interruption of Antiretroviral Treatment: The Strategies for Management of Antiretroviral Therapy (SMART) Study Group. N Engl J Med. 2006, 355: 2283-96. 10.1056\/NEJMoa062360.","journal-title":"N Engl J Med"},{"issue":"5","key":"1063_CR20","first-page":"542","volume":"10","author":"TR Sterling","year":"2006","unstructured":"Sterling TR, Zhao Z, Khan A, Chaisson RE, Schluger N, Mangura B, Weiner M, Vernon A: Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors. Int J Tuberc Lung Dis. 2006, 10 (5): 542-549.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1063_CR21","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1086\/339540","volume":"34","author":"EL Corbett","year":"2002","unstructured":"Corbett EL, Churchyard GJ, Charalambos S, Sam B, Maloi B, Clayton T, Grant AD, Murray J, Hayes RJ, De Cock KM: Morbidity and Mortality in South African Gold Miners: Impact of Untreated Disease Due to Human Immunodeficency Virus. Clinical Infectious Diseases. 2002, 34: 1251-8. 10.1086\/339540.","journal-title":"Clinical Infectious Diseases"},{"key":"1063_CR22","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1097\/QAD.0b013e3282eea47f","volume":"21","author":"NA Martinson","year":"2007","unstructured":"Martinson NA, Karstaedt A, Venter F, Omar T, King P, Mbengo T, Marais E, McIntyre J, Chaisson RE, Hale M: Causes of death in hospitalized adults with a premortem diagnosis of tuberculosis: an autopsy study. AIDS. 2007, 21: 2043-2050. 10.1097\/QAD.0b013e3282eea47f.","journal-title":"AIDS"},{"issue":"2","key":"1063_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1089\/08892220252779629","volume":"18","author":"AG Dirienzo","year":"2002","unstructured":"Dirienzo AG, Horst Van der C, Finkelstein DM, FRAME P, Bozzette SA, Tashima KT: Efficacy of Trimethoprim-Sulfamethoxazole for the Prevention of Bacterial Infections in a Randomized Prophylaxis Trial of Patients with Advanced HIV Infection. AIDS Research and Human retroviruses. 2002, 18 (2): 89-94. 10.1089\/08892220252779629.","journal-title":"AIDS Research and Human retroviruses"},{"key":"1063_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1440-1746.2007.05207.x","volume":"23","author":"A Tostmann","year":"2008","unstructured":"Tostmann A, Boeree MJ, Aarnoutse RE, de Lange WCM, Ven van der AJAM, Dekhuijzen R: Antituberculosis drug-induced hepatotoxicity: Concise up-to-date review. Journal of Gastroenterology and Hepatology. 2008, 23: 192-202. 10.1111\/j.1440-1746.2007.05207.x.","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"1063_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00002030-200201040-00010","volume":"16","author":"GL Dean","year":"2002","unstructured":"Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, Navaratne L, Fisher M, Taylor GP, Miller R, Taylor CB, de Ruiter A, Pozniak AL: Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS. 2002, 16: 75-83. 10.1097\/00002030-200201040-00010.","journal-title":"AIDS"},{"issue":"5","key":"1063_CR26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1086\/596764","volume":"48","author":"G Meintjes","year":"2009","unstructured":"Meintjes G, Rangaka MX, Maartens G, Rebe K, Morroni C, Pepper DJ, Wilkinson KA, Wilkinson RJ: Novel relationship between tuberculosis immune reconstitution inflammatory syndrome and antituberculosis drug resistance. Clin Infect Dis. 2009, 48 (5): 667-76. 10.1086\/596764.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-10-83\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-83.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-83","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-83.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T07:34:12Z","timestamp":1548142452000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-10-83"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,30]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1063"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-10-83","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,30]]},"article-number":"83"}}